-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
It is only for medical professionals to read and refer to clinical information.
1s Touch Venous Thromboembolism (VTE) mainly refers to the abnormal blood coagulation state in the deep venous vascular cavity, which causes vascular blockage, causing blood to fail to flow back into the venous blood vessels smoothly [1]
.
In recent years, there have been more and more researches on rheumatic diseases, and the problem of rheumatoid arthritis (RA) complicated by VTE has gradually attracted widespread attention [2]
.
Recently, the top journal of rheumatology, Ann Rheum Dis, published a national cohort study in Sweden, which assessed the incidence of VTE in RA patients relative to non-RA individuals, and explored the relationship between the clinical disease activity of RA patients and the risk of VTE.
Let’s take a look at today’s newsletter! References[1] MARURACHER LM, POSCH F, MARTINOD K, et al.
Citrullinated histone H3, a biomarker of neutrophil extracellular trap formation, predicts the risk of venous thromboembolism in cancer patients[J].
J Thromb Haemost, 2018, 16( 3): 508-518.
[2] Wang Qing.
Risk assessment and risk factor analysis of venous thromboembolism in patients with rheumatoid arthritis [D].
Dalian Medical University, 2021.
For more cutting-edge clinical information, follow clinical assistants in the medical field for this article Source: Clinical Assistant Editor: Xiao Dangdang and Sun Ying.
The medical community strives for the accuracy and reliability of the published content when it passes the review, but does not know the timeliness of the published content, and the accuracy and completeness of the cited information (if any) It makes any promises and guarantees, and does not assume any responsibility for the outdated content and the possible inaccuracy or incompleteness of the cited information
.
Relevant parties are requested to check separately when adopting or using this as a basis for decision-making
.
1s Touch Venous Thromboembolism (VTE) mainly refers to the abnormal blood coagulation state in the deep venous vascular cavity, which causes vascular blockage, causing blood to fail to flow back into the venous blood vessels smoothly [1]
.
In recent years, there have been more and more researches on rheumatic diseases, and the problem of rheumatoid arthritis (RA) complicated by VTE has gradually attracted widespread attention [2]
.
Recently, the top journal of rheumatology, Ann Rheum Dis, published a national cohort study in Sweden, which assessed the incidence of VTE in RA patients relative to non-RA individuals, and explored the relationship between the clinical disease activity of RA patients and the risk of VTE.
Let’s take a look at today’s newsletter! References[1] MARURACHER LM, POSCH F, MARTINOD K, et al.
Citrullinated histone H3, a biomarker of neutrophil extracellular trap formation, predicts the risk of venous thromboembolism in cancer patients[J].
J Thromb Haemost, 2018, 16( 3): 508-518.
[2] Wang Qing.
Risk assessment and risk factor analysis of venous thromboembolism in patients with rheumatoid arthritis [D].
Dalian Medical University, 2021.
For more cutting-edge clinical information, follow clinical assistants in the medical field for this article Source: Clinical Assistant Editor: Xiao Dangdang and Sun Ying.
The medical community strives for the accuracy and reliability of the published content when it passes the review, but does not know the timeliness of the published content, and the accuracy and completeness of the cited information (if any) It makes any promises and guarantees, and does not assume any responsibility for the outdated content and the possible inaccuracy or incompleteness of the cited information
.
Relevant parties are requested to check separately when adopting or using this as a basis for decision-making
.
